| Literature DB >> 32403123 |
Sara Sadat Aghamiri1, Vidisha Singh1, Aurélien Naldi2, Tomáš Helikar3, Sylvain Soliman4, Anna Niarakis1.
Abstract
MOTIVATION: Molecular interaction maps have emerged as a meaningful way of representing biological mechanisms in a comprehensive and systematic manner. However, their static nature provides limited insights to the emerging behaviour of the described biological system under different conditions. Computational modelling provides the means to study dynamic properties through in silico simulations and perturbations. We aim to bridge the gap between static and dynamic representations of biological systems with CaSQ, a software tool that infers Boolean rules based on the topology and semantics of molecular interaction maps built with CellDesigner.Entities:
Mesh:
Year: 2020 PMID: 32403123 PMCID: PMC7575051 DOI: 10.1093/bioinformatics/btaa484
Source DB: PubMed Journal: Bioinformatics ISSN: 1367-4803 Impact factor: 6.937
Fig. 1.The repertoire of CellDesigner graphical notation schemes used to illustrate CaSQ’s rules. For CaSQ’s conversion rules, we use the notation schemes for association, transport, catalysis, state transition and also the glyphs for receptor, protein, modified protein (here, we show phosphorylation as an example) and the empty set. The empty set can account for degradation or in SBGN-PD terms, can represent the creation (respectively, the disappearance) of an entity from an unspecified source (resp. sink) that we do not need or wish to explicit
Fig. 2.Illustration of the 1st rule. If two species of the map are only reactants in a heterodimer association, and if one of the reactants is annotated as a receptor, then the receptor is deleted from the map (its annotations are added to the product of the reaction)
Fig. 3.Illustration of the 2nd rule. Compression of the complex formation, where none of the reactants is denoted as a receptor, and both reactants do not participate in any other reaction. As a result, both reactants are removed and modifiers are rewired to have the complex as a product
Fig. 4.Illustration of the 3rd rule. Removing inactive forms that do not participate in other reactions
Fig. 5.Combination of rules 2 and 3. CaSQ retains components that contribute further to the propagation of the signal
Fig. 6.Combination of the 2nd and the 4th rule. Components that are translocated across other compartments (e.g. transcription factors) are merged in one component that inherits all influences, provided that the original component does not participate in another reaction/regulation
Size (number of components) of the CaSQ-inferred model using the default and BCC options
| Map name | Map size | SBGN use | CaSQ-inferred model | |||
|---|---|---|---|---|---|---|
| Size | Graph reduction (%) | BCC size | Graph reduction(%) | |||
| Mast cell | 125 | No | 80 | 36 | 73 | 42 |
| MAPK | 232 | No | 182 | 21 | 181 | 22 |
| Cholecystokinin | 530 | No | 404 | 24 | 383 | 28 |
| RA | 779 | Yes | 431 | 45 | 391 | 50 |
| Alzheimer’s | 1361 | No | 1169 | 14 | 762 | 44 |
The existence of a corresponding manually built logical model.
Comparison of CaSQ-inferred Boolean models with manually built models (MM)
| Map name | Map size | SBGN use | MM | CaSQ-inferred model BCC | Common nodes (%) | ||
|---|---|---|---|---|---|---|---|
| Size | Graph reduction (%) | Size | Graph reduction (%) | ||||
| Mast cell | 125 | No | 47 | 62 | 73 | 42 | 64 |
| MAPK | 232 | No | 53 | 77 | 181 | 22 | 79 |
Fig. 7.(a) Screenshot of simulations for Btk knockout of the CaSQ-derived mast cell activation model using Cell Collective. When Btk is set to zero, Erk and PLCG1 are not expressed. (b) Screenshot of simulations for Syk knockout of the CaSQ-derived mast cell activation model using Cell Collective. When Syk is set to zero, Erk, JNK, NFAT, NFkB, Ca2+, PKC, Elk1, PLCG1 are not expressed
Biological data and corresponding behaviours of the manually built and the CaSQ-inferred models for MAPK
| Biological data | Manually built MAPK model | CaSQ-inferred MAPK model | Agreement |
|---|---|---|---|
| 1.JNK might reduce RAS-dependent tumour formation by inhibiting proliferation and promoting apoptosis ( |
|
| Yes |
| 2.HSP90 inhibitor disrupts EGFR, RAF and AKT leading to successful cancer treatment ( |
|
| Yes |
| 3.P38 and JNK play important roles in stress responses such as cell cycle arrest and apoptosis ( |
|
| Yes |
| 4.P38 and JNK, especially in the absence of mitogenic stimuli, have been shown to induce apoptotic cell death ( |
|
| Partial |
| 5.ERK increases transcription of the cyclin genes and facilitates the formation of active Cyk/CDK complexes, leading to cell proliferation ( |
|
| Partial |
| 6.RAF or RAS overexpression can lead to constitutive activation of ERK ( |
|
| No |
Fig. 8.Simulations of the CaSQ-inferred model using the modelling platform Cell Collective. The CaSQ-inferred model for MAPK was able to reproduce known biological scenarios, either completely or partially. The results of the in silico simulations for the three first biological conditions described in Table 3 showed perfect agreement with the results of manually built model, as depicted in a, b and c. For conditions described in scenarios 4 and 5 of Table 3, the CaSQ-inferred model could partially reproduce the attended behaviour (d and e) while simulation results for scenario 6, were inconsistent with the literature and the results of the manually built model (f, g and h)